Skip to main content

Table 1 Characteristics of study participants before and after treatment

From: Randomized trial of acupoints herbal patching in Sanfu Days for asthma in clinical remission stage

Variable

Before treatment

After treatment

Acupoints herbal patching mean (SD)

Placebo mean (SD)

P

Acupoints herbal patching mean (SD)

Placebo mean (SD)

P

Age–year

44.28 ± 17.15

44.53 ± 17.83

0.90

 

Gender—no. (%)

 Male

73 (44.24)

69 (43.67)

0.92

 Female

92 (55.76)

89 (56.32)

Duration of asthma—year

21.13 ± 21.08

22.74 ± 22.68

0.51

Asthma-related symptoms—no. of days in previous 1 yeara

10.25 ± 12.26

7.97 ± 10.94

0.08

   

Asthma-related symptoms—no. of days during the treatment

   

2.58 ± 0.47

2.68 ± 0.48

0.88

Lung function

 FEV1

2.13 ± 1.08

2.07 ± 1.00

0.57

2.04 ± 0.41

2.12 ± 0.42

0.14

 FEV1: FVC × 100

85.97 ± 13.85

86.25 ± 13.93

0.86

87.36 ± 0.66

87.20 ± 0.67

0.87

Asthma-related health care use—no. (%)

 ≥1 admit to A&Eb

48 (29)

46 (29)

1.00

4 (3)

3 (3)

0.73

 ≥1 hospitalization

26 (16)

29 (18)

0.54

3 (2)

2 (2)

0.68

 ≥1 outpatient visit

134 (81)

134 (84)

0.39

13(12)

14 (12)

0.77

 ≥1 prescription

139 (84)

136 (86)

0.64

65 (53)

57 (48)

0.44

 ≥1 by own medication

34 (21)

24 (15)

0.21

2 (2)

2 (2)

0.97

 ≥1 didn’t need treatment

26 (16)

17 (11)

0.19

8 (7)

6 (5)

0.63

The frequency of bronchodilator during asthma attack—no. (%)

0.21

0.72

More than twice per day

37 (22)

29 (18)

 

13 (11)

13 (11)

 

Once to twice per day

50 (30)

62 (39)

34 (28)

33 (28)

2–3 times per week

12 (7)

18 (11)

3 (2)

2 (2)

Less than once per week

48 (29)

36 (23)

13 (11)

7 (6)

Never

18 (11)

13 (8)

60 (49)

64 (54)

Symptoms which frequently appeared in asthma participants—no. of symptomsc

9.12 ± 4.28

9.22 ± 4.18

0.83

3.92 ± 0.34

4.01 ± 0.37

0.85

  1. Plus-minus value are mean ± SD. P values for the comparison of means and percentages were calculated with the use of Chi-square test for categorical variables and the independent-samples test for continuous variables. FEV1, FVC
  2. aThe number of days with symptoms was calculated as the largest of the following variables during the previous 1 month: the number of days with wheezing, cough, chest tightness, or nighttime sleep disruption. This symptom scale ranges from 0–30 days
  3. bAccident and emergency departments (A and E)
  4. cThe total number of symptoms which frequently appeared in asthma participants are 23